Literature DB >> 17895628

Association of ultrasound findings with decision to continue Down syndrome pregnancies.

Sandy Perry1, Angela L Woodall, Eva K Pressman.   

Abstract

OBJECTIVE: To evaluate the association of ultrasound findings and other factors with the decision to terminate trisomy-21-affected pregnancies.
METHODS: We performed a retrospective analysis of trisomy-21-affected pregnancies diagnosed prior to 24 weeks' gestation. Data were collected on maternal age, indications for prenatal diagnosis, gestational age at diagnosis, marital status, race, parity and ultrasound findings. Logistic regression, chi(2), t test and Fishers exact test were used for statistical analysis.
RESULTS: Fifty-nine pregnancies were identified with a termination rate of 72.9%. Termination rates were significantly lower in patients with major (50%) or minor (64%) ultrasound abnormalities than in patients with normal ultrasound exams (92%), p = 0.026 and 0.022, respectively. Patients who chose terminations were older (36.1 vs. 32.3), but this did not reach statistical significance (p = 0.059).
CONCLUSION: Patients with abnormal ultrasound results were more likely to continue a trisomy 21 pregnancy. (c) 2007 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2007        PMID: 17895628     DOI: 10.1159/000106561

Source DB:  PubMed          Journal:  Community Genet        ISSN: 1422-2795


  3 in total

1.  Variables influencing pregnancy termination following prenatal diagnosis of fetal chromosome abnormalities.

Authors:  Anne Hawkins; Ana Stenzel; Joanne Taylor; Valerie Y Chock; Louanne Hudgins
Journal:  J Genet Couns       Date:  2012-09-23       Impact factor: 2.537

2.  A Qualitative Study of Factors Influencing Decision-Making after Prenatal Diagnosis of down Syndrome.

Authors:  Amy R Reed; Kathryn L Berrier
Journal:  J Genet Couns       Date:  2016-12-29       Impact factor: 2.537

3.  A Cost-Effectiveness Analysis of First Trimester Non-Invasive Prenatal Screening for Fetal Trisomies in the United States.

Authors:  Brandon S Walker; Richard E Nelson; Brian R Jackson; David G Grenache; Edward R Ashwood; Robert L Schmidt
Journal:  PLoS One       Date:  2015-07-02       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.